GlassScriptPhysician profile
Vikram K Rao
NPI 1881637825
$137,322.64
in general payments reported to CMS, 2019-2025
55 companies · $29K in 2025
The $29K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $20K · 2021: $25K · 2022: $15K · 2023: $11K · 2024: $4,511 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $22K · Food and Beverage: $16K · Consulting Fee: $3,488 · Travel and Lodging: $2,815 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $22,092.90 |
| Food and Beverage | $16,061.82 |
| Consulting Fee | $3,487.50 |
| Travel and Lodging | $2,814.83 |
| Education | $127.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,251.27 | 2019-2025 | Jeti, Esprit, Perclose Proglide |
| Convatec INC. | $22,163.88 | 2021-2025 | |
| Medtronic, INC. | $16,211.37 | 2021-2025 | Hawkone, Na, Endurant Iis |
| Medtronic Vascular, INC. | $14,242.41 | 2019-2020 | |
| Boston Scientific Corporation | $13,622.88 | 2019-2025 | General - Angiography, Eluvia, Embold Fibered |
| Penumbra, INC. | $11,540.09 | 2019-2024 | Indigo System, Penumbra System |
| Endologix LLC | $8,299.84 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Bolton Medical INC | $3,958.06 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Ethicon INC. | $3,865.40 | 2021 | |
| Shockwave Medical, INC | $2,994.08 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $1,654.38 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $633.68 | 2019-2025 | Lifestream, Crosser Iq |
| Cardiva Medical, INC. | $526.66 | 2021-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $427.83 | 2022-2025 | (P84) Igt Devices Systems, (6346) Intrasight Mobile, (Br5) Peripheral Ivus |
| Argon Medical Devices, INC. | $355.91 | 2019-2023 | Ivcf |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $290.28 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $285.49 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $271.58 | 2021-2022 | |
| Integra Lifesciences Corporation | $229.25 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Silk Road Medical, INC. | $210.47 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Inari Medical, INC. | $198.56 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $167.78 | 2022-2023 | Saber |
| Ekos Corporation | $159.69 | 2019 | |
| Organogenesis INC. | $159.67 | 2025 | Cygnus Dual |
| Shape Memory Medical INC. | $157.20 | 2025 | Impede Embolization Plug |
| Cagent Vascular INC | $125.80 | 2025 | Serrantor |
| Becton, Dickinson and Company | $119.29 | 2024 | Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $111.68 | 2019-2023 | Azur Cx Detachable, Navicross, Glidesheath Slender |
| Avinger INC. | $105.97 | 2019-2023 | Pantheris |
| Pfizer INC. | $103.25 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $99.30 | 2019-2023 | |
| Abiomed | $92.95 | 2019-2023 | Impella |
| Imperative Care, INC | $82.92 | 2025 | Symphony Catheter |
| Ethicon US, LLC | $60.66 | 2019-2024 | Stratafix |
| Portola Pharmaceuticals, LLC | $58.25 | 2019 | |
| Lemaitre Vascular, INC. | $55.20 | 2019-2025 | Restoreflow, Trivex System |
| Angiodynamics, INC. | $45.62 | 2021-2024 | Alphavac |
| Alexion Pharmaceuticals, INC. | $41.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.33 | 2023-2025 | |
| Amgen INC. | $29.04 | 2019-2024 | Repatha |
| Mimedx Group, INC. | $27.92 | 2024 | |
| Novo Nordisk INC | $25.74 | 2025 | Wegovy |
| Depuy Synthes Sales INC. | $24.83 | 2024 | Matrixrib |
| Heartflow, INC. | $24.13 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.70 | 2024 | Jardiance |
| Covidien LP | $21.41 | 2020 | |
| Stryker Corporation | $20.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Getinge USA Sales, LLC | $18.22 | 2021 | |
| Solventum Corporation | $18.15 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Astrazeneca Pharmaceuticals LP | $17.12 | 2023 | Brilinta |
| Smith+Nephew, INC. | $16.67 | 2024 | Pico 7, Renasys Touch |
| Reflow Medical INC | $15.57 | 2025 | |
| Mozarc Medical US LLC | $13.82 | 2023 | Chameleon |
| Thrombolex, INC. | $12.70 | 2025 | Bashir Endovascular Catheter |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$102,315.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.